| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.7 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |